Avantax Planning Partners, Inc. Novo Nordisk A S Transaction History
Avantax Planning Partners, Inc.
- $2.78 Billion
- Q3 2024
A detailed history of Avantax Planning Partners, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Avantax Planning Partners, Inc. holds 2,307 shares of NVO stock, worth $234,714. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,307
Previous 3,656
36.9%
Holding current value
$234,714
Previous $521,000
47.41%
% of portfolio
0.01%
Previous 0.02%
Shares
9 transactions
Others Institutions Holding NVO
# of Institutions
1,953Shares Held
320MCall Options Held
5.49MPut Options Held
7.78M-
Jennison Associates LLC20.2MShares$2.05 Billion1.5% of portfolio
-
Morgan Stanley New York, NY14.4MShares$1.46 Billion0.13% of portfolio
-
Bank Of America Corp Charlotte, NC14.3MShares$1.46 Billion0.14% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.3MShares$1.35 Billion0.65% of portfolio
-
Fayez Sarofim & CO Houston, TX12.2MShares$1.24 Billion3.76% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $230B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...